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Tetralogy of fallot is a congenital cardiac malformation that consists of an interventricular miscommunication. This combination of lesions occurs 
in three of every 10,000 live births and accounts for 7–10% of all congenital cardiac malformations. It is a condition caused by a combination of 
defects in all the four heart chambers that are present at birth. These defects affect the structure of heart, cause oxygen poor blood to flow out of the 
heart and to the rest of the body. Infants and children with TOF usually have blue tinged skin. The prevalence rate of TOF is 3.5% affecting males and 
females equally. Pneumonia is an infection of lungs that inflames air sacs in one or both lungs. The air sacs may fill with fluid or pus causing cough with 
phlegm, fever, and chills. It is most common in infants and young children and people with weakened immune system. A 12 months’ female child with 
this congenital heart defect and pneumonia was discussed in this report. However, most of the children with TOF need surgery, but timings may vary 
depending on the condition and severity. This is important to note that surgery for TOF is palliative but not curative. This report concludes that there 
is a need to increase awareness of TOF so as to encourage early diagnosis and therefore promotes better outcomes.
Keywords: Tetralogy of fallot, Emergency care, Pulmonary cyanosis, Heart murmurs.
INTRODUCTION
Tetralogy of fallot (TOF) is a congenital heart defect that occurs at birth. 
TOF was first described by Niels Stenson, Danish anatomist in 1672. 
Sandifort Edward describes the symptoms and anatomical findings of 
TOF in a child in 1777 [1]. Significant congenital heart disease may be 
diagnosed virtually at any age but some conditions are discovered in 
rarely identified in infants [2]. It is one of the most common causes 
of cyanotic congenital heart diseases. It accounts for 7–10% of all 
congenital cardiac lesions and affects males and females equally [3]. 
The prevalence of TOF is 3.5% and the child born with TOF in these 
days can expect to survive to adulthood because of advances in the 
surgical treatment [4]. Congenital heart disease is a gross structural 
abnormality characterized by ventricular septal defect (VSD), over-
riding aorta, pulmonary stenosis, and hypertrophy of right ventricle.
TOF has many causes. The major cause is chromosomal abnormalities 
accounts for 25% of cases of child with TOF. It includes triosomes 13, 
18, 21, and 22q 11.2. Among these, most common abnormalities are 
triosomes 21 and 22q 11.2. Moreover, other causes are family history, 
Digeorge syndrome [5]. The common risk factors associated with TOF 
includes viral infections, measles during pregnancy, and maternal 
intake of retinoic acid in first trimester, untreated phenylketonuria, and 
poorly controlled diabetes mellitus in pregnancy [1,5].
However, onset of symptoms and severity depends on degree of right 
ventricular outflow tract obstruction. In mild cases, the patient is 
asymptomatic and acyanosed. The only finding present in such cases 
is systolic murmur. In case of severe obstruction, marked cyanosis may 
be present which requires medical intervention. Signs and symptoms 
become more apparent as the infant grows older. Along with the 
cyanosis, respiratory distress and hyper-cyanotic spells (TET spells) 
may also present [1,5]. These TET spells are life threatening and may 
be fatal which requires intervention. It occurs as a result of spasm of 
right outflow tract. Feeding, crying, and exertion are the precipitating 
factors of TET spells.
The pathology of TOF includes conal septum is displaced anteriorly. 
This displaced conal septum protrudes into the pulmonary outflow 
tract, which may result in obstruction and blockage of downstream 
structures including the pulmonary valve, main pulmonary artery, 
and branch pulmonary arteries. Systolic pressure in the left and right 
ventricles and in the aorta is same because VSD is large. The extent 
of condition depends on the degree of right ventricular outflow 
obstruction. This obstruction may result in a net left to right shunt 
through the VSD, and a severe obstruction leads to a right to left shunt 
resulting in low systemic arterial saturation. TOF is majorly confirmed 
by echocardiography. Clinical diagnosis requires history, and clinical 
examination. Chest X-ray is done to identify boot shaped heart. Right 
ventricular hypertrophy can be identified by electrocardiography. 
Cardiac catheterization can be done in case of suspicion of any coronary 
anomaly. TOF condition is manageable by medication and surgery. The 
mode of management depends on type and degree of right outflow 
obstruction. In case of critical pulmonary stenosis, prostaglandin 
infusion (0.05‒0.1 mcg/kg/min intravenous [IV]) is given to increase 
pulmonary outflow of blood. Surgical intervention is necessary in case 
of severe right ventricular outflow. It includes intra-cardiac repair and 
shunt/bypass surgery [6]. For treating TET spells, calm the child and 
provide supplemental oxygen and infuse IV fluids for volume expansion. 
If the spell persists, standard therapy should be followed. It includes 
beta-blockers (propranolol or esmolol), morphine, phenylephrine, 
intranasal midazolam, and intranasal fentanyl.
PNEUMONIA
Pneumonia is a respiratory condition in which there is an infection of 
the lungs that inflames the air sacs. Globally, pneumonia sustains as the 
leading cause of death of children under 5 years. According to the WHO 
report, pneumonia accounts for 120 million cases every year, among 
which 14 million cases were severe [7]. Pneumonia is caused by variety 
of organisms. The most common causes are bacterial (Streptococcus 
pneumonia, and mycoplasma), virus (flu virus, adenovirus, parainfluenza 
virus, and respiratory syntical virus), and fungus (pneumocystis 
jiroveci). The group of people who are at risk of long-term morbidity 
and mortality is infants (low birth weight or premature), those people 
who are immunocompromised, and those who have other conditions 
such as cystic fibrosis and congenital heart disease. Child can present 
signs and symptoms at different stages of illness. Clinical presentation 
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of pneumonia includes fever, cough, tachypnea, wheezing, abdominal 
pain, and lethargy. Other signs of pneumonia are chest indrawing, 
nasal flaring, cyanosis, breathing difficulty, feeding less than half of 
normal intake, and signs of dehydration. A temperature of >38.5°C is a 
characteristic feature of bacterial pneumonia [8].
Pathology of pneumonia starts with invasion of lower respiratory tract 
by inhalation, aspiration of pathogens. To counteract the pathogens, 
the barrier to infection anatomical structures includes nasal hairs, 
Chest-X ray is still considered as a golden standard for diagnosing 
pneumonia. In general, it is not possible to identify the exact cause of 
pneumonia in the clinical practice. This is because of coinfections of 
bacteria and virus which cannot be distinguished from infection due 
to a single pathogen. Hence, antibiotic therapy is prescribed for all the 
children. The main goal of treatment is to reduce the risk of morbidity 
and mortality of pneumonia as cheaply as possible. In severe pneumonia, 
the recommended first-line drugs are benzyl penicillin, amoxicillin, 
and chloramphenicol. In case of very severe pneumonia, ampicillin, or 
amoxicillin plus gentamicin are recommended [11]. Amoxicillin is the 
first choice for children <5 years old through oral route, alternative are 
coamoxiclav, cefaclor, erythromycin, clarithromycin, and azithromycin. 
At present, resistance of S. pneumonia to penicillin is increased. Hence, 
macrolides are prescribed along with it. The British Thoracic Society 
guidelines suggested that antibiotics administered orally are safe and 
effective and IV antibiotics are preferred for children with severe signs 
and symptoms. In general, oral antibiotics are prescribed for 5–7 days 
but treatment duration is increased to 10 days based on severity 
of disease and antibiotic. The major complications of pneumonia 
are treatment failure, pleural effusion, emphysema, lung abscesses, 
septicemia, etc. [8]. The hospitalization and mortality of pneumonia can 
be reduced by conjugate vaccines against Haemophilus influenza type b 
and S. pneumonia [12].
A CLINICO-PATHOLOGIC STUDY
A 12 months’ female child patient weighing 4.5 kg, resident of kadapa 
was admitted in PICU ward presented with chief complaints of fever, 
cough, cold, and breathlessness since 4 days. The patient’s mother 
noticed bluish discoloration of fingers, toes, lips during irritability, and 
Fig. 1: Tetralogy of fallot with pulmonary atresia
Fig. 2: Congenital cyanotic heart disease
Fig. 3: Bronchi swelling and alveoli filling with mucus
cilia, epiglottis and cell mediated, and humoral immunity activated. As 
a result of these, nasopharyngeal colonization occurs which leads to 
inflammation or injury or death of surrounding epithelium and alveoli. 
The migration of inflammatory cells to the site of infection causing an 
exudative process that impairs oxygenation [9]. A number of different 
laboratory tests ate used currently in combination with the clinical 
assessment to diagnose pneumonia. White blood cells (WBC count), 
C – reactive protein, and erythrocyte sedimentation rate are generally 
used as a markers of infection, but they do not help in distinguishing 
between bacterial, viral, or mixed pneumonia. Blood cultures are 
taken if suspected to have bacterial pneumonia. Polymerase chain 
reaction enhances the identification of specific organism, but it is 
not widely available, expensive and routine use is not recommended. 
Viral immune-fluorescence and viral antigen detection can be done by 
nasopharyngeal aspirate which is useful in identifying virus [8,10].
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excessive crying. Medication history of the patient includes, TOF was 
observed immediate after 10 days of birth. Medication history includes 
Tab. Propranolol 4 mg TID at the age of 9 months. In addition, patient 
was prescribed with syrup Digoxin 12.5 µg (0.25 ml) BD since 1 month. 
Patient was immunized up to the age as per schedule. She was born of 
a full-term cesarean delivery in the hospital without any peripartum 
complications but with low-birth weight of 1.77 kg and not cried 
immediately after birth. Personnel history includes weight – 4.5 kg, 
abnormal sleep, bowel, and bladder habits that were normal, appetite 
was normal. There was no history of similar illness in the family.
On examination, the patient was found to be conscious, coherent, 
and cooperative. She was comfortable at rest. The pulse rate was 
118/min, respiratory rate was 62 cpm, temperature was 100°F. The 
digits of all four limbs and lips are cyanosed and a saturation of 58%. 
On cardiovascular examination, S1 and S2 were normal. Pan-systolic 
murmur was heard, loudest. On respiratory examination bilateral 
coarse crepts also present. Chest X-ray report shows consolidation in 
both lungs at basal fields and liver was not palpable. 2D Echo reveals 
double outlet right ventricle, TOF, straddling of tricuspid valve, and 
mild-to-moderate hypo-plastic left ventricle. During the treatment 
course, the patient oxygen saturation was reduced day-by-day from 
70% to 35%.
Gradually, the patient condition became worsening and dobutamine 
infusion of 1.35cc was given on days 18 and 19. The patient passed 
away on day 20 without undergoing surgical intervention.
DISCUSSION
This is a case of an infant with TOF and bronchopneumonia. In general, 
the diagnosis and clinical management of TOF requires multidisciplinary 
team that includes a pediatrician, pediatric cardiologist, cardiac surgeon, 
radiologist, and pharmacist. However, most of the children with TOF 
need surgery, but timings may vary depending on the condition and 
severity [13]. This patient undergone symptomatic therapy for TOF 
and hyper-cyanotic spells since 10 months and patient passed away at 
the age of 12 months. She does not undergo any intervention. There 
is 75% mortality rate for child with TOF without any intervention and 
70% survival rate for child with TOF who undergone corrective surgery 
either in childhood or adulthood [13].
In US, infants born with TOF undergoes primary repair within 1st year 
of life and outcomes were good but after 20 years majority people 
need pulmonary valve replacement. Nowadays, percutaneous method 
of implanting pulmonary valve is available, in which child is free from 
symptoms but the long-term results were unknown. This is important 
to note that surgery for TOF is palliative but not curative [1]. This case 
demonstrates the challenges faced by the child with cyanotic congenital 
heart disease without any intervention. Hence, this report concludes 
that there is a need to increase awareness of TOF so as to encourage 
early diagnosis and therefore promotes better outcomes. However, 
pharmacist also plays a role in management of TOF by reducing 
medication errors, drug-drug interaction, improvement of usage of 
guideline driven therapy, and promotes medication adherence [14].
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Drug name Dose ROA Frequency Duration 
(days)
Inj. Piptaz 500 mg IV TID 1–17
Inj. Amikacin 40 mg IV OD 1–17
Syp. Ambroxol 1 ml p/o TID 2–15
Syp. Paracetamol 2.5 ml p/o TID 1–3
Neb Budecort 0.3 mcg Nasal 12th hrly 1–17
O2 Inhalation 5 L/min Nasal SOS 1–20
Furoped drops 0.5 ml p/o BD 1–20
Isolyte– P 150 ml IV TID 1–14
Table 1: The patient was treated with following medications
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